41 – 50 of 248
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
A deadly spread: cellular mechanisms of α-synuclein transfer.
(
- Contribution to journal › Article
-
Mark
Journal of Parkinson's Disease Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Systemic administration of Neuregulin-1ß(1) protects dopaminergic neurons in a mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Stage-Specific Modulation of Cortical Neuronal Development by Mmu-miR-134
(
- Contribution to journal › Article
-
Mark
Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease
(
- Contribution to journal › Article
-
Mark
Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
Can alpha-synuclein be targeted in novel therapies for Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
- 2010
-
Mark
Nitric Oxide Stimulates the Proliferation of Neural Stem Cells Bypassing the Epidermal Growth Factor Receptor
(
- Contribution to journal › Article